Wayne Markowitz - 11 Sep 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Sep 2026, 18:04:02 UTC
Prior SEC filing
26 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Linda J. Park, Attorney-in-Fact

Key filing fact

Wayne Markowitz filed Form 4 for Edwards Lifesciences Corp (EW) on 14 Sep 2026.

Key facts

  • This page summarizes Wayne Markowitz's Form 4 filing for Edwards Lifesciences Corp (EW).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Sep 2026, 18:04.

Change

  • Previous filing in this sequence was filed on 26 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001991414 Primary reporting owner

Markowitz Wayne

Relationship
CVP, JAPAC
Address
ONE EDWARDS WAY, IRVINE
Signature
Linda J. Park, Attorney-in-Fact
Signature date
14 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Tax liability

Transaction value
Shares
-355
Change %
-1.7%
Price
$86.77*
Shares after
19,939
Date
11 Sep 2026
Ownership
Direct
Footnotes
F1
EW transaction

Common Stock

Tax liability

Transaction value
Shares
-568
Change %
-2.8%
Price
$84.37*
Shares after
19,371
Date
14 Sep 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .